Frontiers in Plant Science· 2016Q1· Review
Cannabis sativa: The Plant of the Thousand and One Molecules
- 1,536citations
- Q1SCImago
- 2016year
Short summary
Cannabis sativa is a rich source of diverse phytochemicals, including cannabinoids, terpenes, and phenolic compounds, with significant pharmaceutical and industrial applications.
AI-generated from the title and abstract; the full text is not read.
Key points
- Cannabis sativa produces a wide array of phytochemicals, notably cannabinoids, terpenes, and phenolic compounds.
- Cannabinoids are primarily studied for their psychotropic and wide-ranging pharmaceutical effects on human health.
- Terpenes and phenolic compounds, including stilbenoids and lignans, also possess therapeutic and commercial value.
- Biotechnological approaches like plant genetic engineering and tissue culture (cell suspension, hairy root cultures) can enhance secondary metabolite production.
- Trichomes are identified as key structures for phytochemical production within the plant.
AI-generated from the title and abstract; the full text is not read.
Abstract
Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence of interest because of its multi-purpose applications: it is indeed a treasure trove of phytochemicals and a rich source of both cellulosic and woody fibers. Equally highly interested in this plant are the pharmaceutical and construction sectors, since its metabolites show potent bioactivities on human health and its outer and inner stem tissues can be used to make bioplastics and concrete-like material, respectively. In this review, the rich spectrum of hemp phytochemicals is discussed by putting a special emphasis on molecules of industrial interest, including cannabinoids, terpenes and phenolic compounds, and their biosynthetic routes. Cannabinoids represent the most studied group of compounds, mainly due to their wide range of pharmaceutical effects in humans, including psychotropic activities. The therapeutic and commercial interests of some terpenes and phenolic compounds, and in particular stilbenoids and lignans, are also highlighted in view of the most recent literature data. Biotechnological avenues to enhance the production and bioactivity of hemp secondary metabolites are proposed by discussing the power of plant genetic engineering and tissue culture. In particular two systems are reviewed, i.e., cell suspension and hairy root cultures. Additionally, an entire section is devoted to hemp trichomes, in the light of their importance as phytochemical factories. Ultimately, prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.
The authors' abstract, as published at the source. Frontiers in Plant Science, 2016 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pharmacology (Medicine)
PharmacologyMedicine